120 related articles for article (PubMed ID: 16127182)
1. Plasma matrix metalloproteinase-8 concentrations are associated with the presence and severity of coronary artery disease.
Kato R; Momiyama Y; Ohmori R; Taniguchi H; Nakamura H; Ohsuzu F
Circ J; 2005 Sep; 69(9):1035-40. PubMed ID: 16127182
[TBL] [Abstract][Full Text] [Related]
2. Plasma Soluble Endoglin Levels Are Inversely Associated With the Severity of Coronary Atherosclerosis-Brief Report.
Saita E; Miura K; Suzuki-Sugihara N; Miyata K; Ikemura N; Ohmori R; Ikegami Y; Kishimoto Y; Kondo K; Momiyama Y
Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):49-52. PubMed ID: 27789477
[TBL] [Abstract][Full Text] [Related]
3. Associations between plasma nesfatin-1 levels and the presence and severity of coronary artery disease.
Ibe S; Kishimoto Y; Niki H; Saita E; Umei T; Miura K; Ikegami Y; Ohmori R; Kondo K; Momiyama Y
Heart Vessels; 2019 Jun; 34(6):965-970. PubMed ID: 30599062
[TBL] [Abstract][Full Text] [Related]
4. Plasma metalloproteinase-12 and tissue inhibitor of metalloproteinase-1 levels and presence, severity, and outcome of coronary artery disease.
Jguirim-Souissi I; Jelassi A; Addad F; Hassine M; Najah M; Ben Hamda K; Maatouk F; Ben Farhat M; Bouslema A; Rouis M; Slimane MN
Am J Cardiol; 2007 Jul; 100(1):23-7. PubMed ID: 17599435
[TBL] [Abstract][Full Text] [Related]
5. High plasma levels of matrix metalloproteinase-8 in patients with unstable angina.
Momiyama Y; Ohmori R; Tanaka N; Kato R; Taniguchi H; Adachi T; Nakamura H; Ohsuzu F
Atherosclerosis; 2010 Mar; 209(1):206-10. PubMed ID: 19674746
[TBL] [Abstract][Full Text] [Related]
6. Plasma osteopontin levels are associated with the presence and extent of coronary artery disease.
Ohmori R; Momiyama Y; Taniguchi H; Takahashi R; Kusuhara M; Nakamura H; Ohsuzu F
Atherosclerosis; 2003 Oct; 170(2):333-7. PubMed ID: 14612215
[TBL] [Abstract][Full Text] [Related]
7. Serum matrix metalloproteinase-9 concentration in angiographically assessed coronary artery disease.
Kalela A; Koivu TA; Sisto T; Kanervisto J; Höyhtyä M; Sillanaukee P; Lehtimäki T; Nikkari ST
Scand J Clin Lab Invest; 2002; 62(5):337-42. PubMed ID: 12387578
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast growth factor 23 is associated with the presence of coronary artery disease and the number of stenotic vessels.
Hu X; Ma X; Pan X; Hao Y; Luo Y; Lu Z; Bao Y; Jia W
Clin Exp Pharmacol Physiol; 2015 Nov; 42(11):1152-7. PubMed ID: 26217893
[TBL] [Abstract][Full Text] [Related]
9. Increased serum concentrations of pentosidine are related to presence and severity of coronary artery disease.
Kerkeni M; Weiss IS; Jaisson S; Dandana A; Addad F; Gillery P; Hammami M
Thromb Res; 2014 Sep; 134(3):633-8. PubMed ID: 25065554
[TBL] [Abstract][Full Text] [Related]
10. Association between Plasma Sestrin2 Levels and the Presence and Severity of Coronary Artery Disease.
Kishimoto Y; Aoyama M; Saita E; Ikegami Y; Ohmori R; Kondo K; Momiyama Y
Dis Markers; 2020; 2020():7439574. PubMed ID: 32670435
[TBL] [Abstract][Full Text] [Related]
11. High Plasma Levels of Soluble Talin-1 in Patients with Coronary Artery Disease.
Aoyama M; Kishimoto Y; Saita E; Ikegami Y; Ohmori R; Nakamura M; Kondo K; Momiyama Y
Dis Markers; 2020; 2020():2479830. PubMed ID: 32566035
[TBL] [Abstract][Full Text] [Related]
12. Elevated lipoprotein (a) levels are associated with the presence and severity of coronary artery disease in patients with type 2 diabetes mellitus.
Zhang HW; Zhao X; Guo YL; Gao Y; Zhu CG; Wu NQ; Li JJ
Nutr Metab Cardiovasc Dis; 2018 Oct; 28(10):980-986. PubMed ID: 30030022
[TBL] [Abstract][Full Text] [Related]
13. Plasma matrix metalloproteinase-3 level is an independent prognostic factor in stable coronary artery disease.
Wu TC; Leu HB; Lin WT; Lin CP; Lin SJ; Chen JW
Eur J Clin Invest; 2005 Sep; 35(9):537-45. PubMed ID: 16128859
[TBL] [Abstract][Full Text] [Related]
14. Association between Plasma Follistatin-like Protein 1 Levels and the Presence and Severity of Coronary Artery Disease.
Yamazaki Y; Kishimoto Y; Saita E; Aoyama M; Ikegami Y; Ohmori R; Tanimoto K; Kondo K; Momiyama Y
Int Heart J; 2021; 62(6):1207-1212. PubMed ID: 34853217
[TBL] [Abstract][Full Text] [Related]
15. High-density lipoprotein cholesterol efflux capacity as a relevant predictor of atherosclerotic coronary disease.
Ishikawa T; Ayaori M; Uto-Kondo H; Nakajima T; Mutoh M; Ikewaki K
Atherosclerosis; 2015 Sep; 242(1):318-22. PubMed ID: 26246268
[TBL] [Abstract][Full Text] [Related]
16. Association of circulating matrix metalloproteinase-1, but not adiponectin, with advanced coronary artery disease.
Hwang JJ; Yang WS; Chiang FT; Chen MF; Lin HJ; Huang PJ; Hsu SH; Lai SK; Wu YW
Atherosclerosis; 2009 May; 204(1):293-7. PubMed ID: 18823886
[TBL] [Abstract][Full Text] [Related]
17. Plasma matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-2, and CD40 ligand levels in patients with stable coronary artery disease.
Tayebjee MH; Lip GY; Tan KT; Patel JV; Hughes EA; MacFadyen RJ
Am J Cardiol; 2005 Aug; 96(3):339-45. PubMed ID: 16054454
[TBL] [Abstract][Full Text] [Related]
18. ADAMTS-5 Decreases in Coronary Arteries and Plasma from Patients with Coronary Artery Disease.
Wang Z; Ye D; Ye J; Wang M; Liu J; Jiang H; Xu Y; Zhang J; Chen J; Wan J
Dis Markers; 2019; 2019():6129748. PubMed ID: 31929842
[TBL] [Abstract][Full Text] [Related]
19. High Plasma Levels of Legumain in Patients with Complex Coronary Lesions.
Umei TC; Kishimoto Y; Aoyama M; Saita E; Niki H; Ikegami Y; Ohmori R; Kondo K; Momiyama Y
J Atheroscler Thromb; 2020 Jul; 27(7):711-717. PubMed ID: 31735728
[TBL] [Abstract][Full Text] [Related]
20. Association between abdominal aortic plaque and coronary artery disease.
Li W; Luo S; Luo J; Liu Y; Huang W; Chen J
Clin Interv Aging; 2016; 11():683-8. PubMed ID: 27279740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]